Evaluating the Determinants of Choosing In-House Versus Outsourced Genetic Services in Thai Hospitals: A Case Study of Bumrungrad International Hospital

Abstract

This study investigates the key factors influencing the decision between offering in-house genetic services versus outsourcing these services at Bumrungrad International Hospital in Thailand. The hospital, prioritized for its patient-centered approach, faces a critical operational decision that impacts cost management, turnaround time, and overall service quality. The research focuses on exploring the cost-effectiveness, patient preferences, service lead times, and collaboration with specialized laboratories, while also investigating the role of local expertise and technical teams in supporting in-house services. Data were collected through in-depth interviews with healthcare professionals at various levels, revealing that in-house genetic services generally offer faster turnaround times and better integration with existing infrastructure, but require significant initial investment. The study highlights the importance of cost management strategies, patient-centered service development, efficient lead time management, strategic collaborations, and continuous staff training to ensure high standards of genetic services. The findings suggest that a balanced approach combining in-house capabilities with strategic outsourcing can optimize both operational efficiency and patient satisfaction